Press Release Forum [pressreleaseforum.com] Forum Index

Press Release Forum [pressreleaseforum.com]
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!

 

AnaSpec Now Offers Custom Synthesis of Stapled Helical Pepti

 
Post new topic   Reply to topic    Press Release Forum [pressreleaseforum.com] Forum Index -> Biotech Press Releases
View previous topic :: View next topic  
Author Message
anaspec



Joined: 15 Aug 2006
Posts: 238
Location: 34801 Campus Drive, Fremont, CA 94555

PostPosted: Mon Mar 23, 2009 12:43 pm    Post subject: AnaSpec Now Offers Custom Synthesis of Stapled Helical Pepti Reply with quote

San Jose, CA – March 23, 2009

AnaSpec has announced the availability of stapled helical peptides custom synthesis service. Unnatural amino acid (S5 and R8) substitutions flank three (substitution positions i and i + 4 using S5 and S5, e.g. .-S5-.-S5-.) or six standard amino acids (i and i + 7 using R8 and S5, e.g. .-R8-.-S5-.).

Many biological pathways, such as signal transduction, occur because of intracellular protein-protein interactions, which frequently are mediated by the α-helix structures of proteins; however, the use of short protein fragments (peptides) generally leads to the loss of secondary structure, such as alpha helical structure. Short peptides also are easily degraded by proteolysis and have difficulty in intact cells penetration.1 Verdine’s group has shown that these problems could be overcome by a chemical modification of an alpha-helical peptide they termed hydrocarbon-stapled peptide.1,2 The modified hydrocarbon-stapled peptide was helical and relatively protease resistant. The modification resulted in cell-permeable peptides that bind with increased binding affinity for its target, and may provide a useful strategy for experimental and therapeutic modulation of protein-protein interactions in many signaling pathways related to apoptosis in cancer cells as well as in vivo pharmacokinetics and efficacy in disease models.

About AnaSpec

AnaSpec is a leading provider of integrated proteomics solutions to the world’s largest biotech, pharmaceutical, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.

For more information visit www.anaspec.com

References:
1. Walensky, LD. et al. Science 305, 1466 (2004).
2. Schafmeister, CE. et al. J. Am. Chem. Soc. 122, 5891 (2002).
3. Zhang, HT. et al. J. Mol. Biol. 378(3), 565-580 (2008).


###
_________________
Ping Yang
Marketing Speialist
34801 Campus Drive
Fremont, CA 94555
1-800-452-5530 (Toll free)
1-510-791-9560 (Tel)
1-510-791-9572 (Fax)
ping@anaspec.com
www.anaspec.com
Back to top
View user's profile Send private message Send e-mail Visit poster's website
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [pressreleaseforum.com] Forum Index -> Biotech Press Releases All times are GMT - 4 Hours
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release

 

 
Editor's pick: